Skip to main content
. Author manuscript; available in PMC: 2014 Sep 8.
Published in final edited form as: Addict Biol. 2011 Nov 9;18(2):379–391. doi: 10.1111/j.1369-1600.2011.00407.x

Table 3.

N-acetylaspartate measures (institutional units). Mean (SD).

Control
nsALC
sALC
Effect size (Cohen’s d)
Variable (n = 33) (n = 25) (n = 36) CON
versus nsALC
CON
versus sALC
nsALC
versus sALC
ACC 29.85 (3.85) 30.23 (3.25) 29.89 (3.90) 0.11 0.01 0.10
DLPFC 33.39 (3.90) 33.36 (3.74) 31.05 (3.79)a,b 0.01 0.62 0.61
Insula 32.23 (3.33) 32.88 (3.53) 30.57 (3.15)a,b 0.19 0.49 0.68
Vermis 33.01 (5.97) 35.77 (5.62) 32.62 (5.92)b 0.47 0.08 0.54
SCR 32.28 (3.04) 31.37 (2.95) 29.49 (3.22)a,b 0.30 0.90 0.61
Total BRS 32.52 (3.88) 32.72 (3.97) 30.42 (3.95)a,b 0.12 0.45 0.58
Total frontal neocortex 31.76 (3.91) 31.40 (3.76) 31.33 (3.64) 0.09 0.12 0.02
Global neocortex 30.57 (3.51) 30.54 (3.61) 30.46 (3.46) 0.01 0.03 0.02
a

sALC < CON, P ≤ 0.024;

b

sALC < nsALC, P ≤ 0.024.

ACC = anterior cingulate cortex; BRS = brain reward system; CON = Control; DLPFC = dorsolateral prefrontal cortex; nsALC = non-smoking alcohol-dependent participant; OFC = orbitofrontal cortex; sALC = smoking alcohol-dependent participant; SCR = superior corona radiata.